The primary inhibitor of plasmin in human plasma

Author:

Müllertz S1,Clemmensen I1

Affiliation:

1. Department of Clinical Chemistry, University of Copenhagen, Hvidovre Hospital, 2650 Hvidovre, Denmark

Abstract

A complex between plasmin and an inhibitor was isolated by affinity chromatography from urokinase-activated human plasma. The complex did not react with antibodies against any of the known proteinase inhibitors in plasma. A rabbit antiserum against the complex was produced. It contained antibodies agianst plasminogen+plasmin and an α2 protein. By crossed immunoelectrophoresis the α2 protein was shown to form a complex with plasmin, when generated by urokinase in plasma, and with purified plasmin. The α2 protein was eluted by Sephadex G-200 gel filtration with KD approx. 0.35, different from the other inhibitors of plasmin in plasma, and corresponding to an apparent relative molecular mass (Mr) of about 75000. By sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the Mr of the complex was found to be approx. 130000. After reduction of the complex two main bands of protein were observed, with Mr, about 72000 and 66000, probably representing an acyl-enzyme complex of plasmin-light chain and inhibitor-heavy chain, and a plasmin-heavy chain. A weak band with Mr 9000 was possibly an inhibitor-light chain. The inhibitor was partially purified and used to titrate purified plasmin of known active-site concentration. The inhibitor bound plasmin rapidly and strongly. Assuming an equimolar combining ratio, the concentration of active inhibitor in normal human plasma was estimated to be 1.1 μmol/1. A fraction about 0.3 of the antigenic inhibitor protein appeared to be functionally inactive. In plasma, plasmin is primarily bound to the inhibitor. Only after its saturation does lysis of fibrinogen and fibrin occur and a complex between plasmin and α2 macroglobulin appear.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry

Cited by 187 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The fibrinolysis renaissance;Journal of Thrombosis and Haemostasis;2023-12

2. СОВЕТ ИТТИФОҚИ ЙИЛЛАРИДА ЎЗБЕКИСТОНДА МАДАНИЙ ТУРИЗМНИНГ ТУРИЗМ ИНДУСТРИЯСИДАГИ ЎРНИ ВА АҲАМИЯТИ;Ижтимоий-гуманитар фанларнинг долзарб муаммолари / Актуальные проблемы социально-гуманитарных наук / Actual Problems of Humanities and Social Sciences.;2023-06-06

3. Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1);Seminars in Thrombosis and Hemostasis;2022-12-15

4. Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target;TH Open;2022-10

5. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics;International Journal of Molecular Sciences;2021-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3